Material Event (Form 8-K)

Item 8.01 Other Events.

As previously disclosed, on September 16, 2024, DarioHealth Corp. (the "Company") received a letter from the listing qualifications staff (the "Staff") of the Nasdaq Stock Market ("Nasdaq") notifying the Company that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. On September 12, 2025, the Company received a letter from the Staff notifying the Company that the Staff has determined that for the last 10 consecutive business days, from August 28, 2025 to September 11, 2025, the closing bid price of the Company's common stock had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and the matter is now closed.